The record
J&J's Form 10-K for fiscal year 2023 (filed February 16, 2024) carries an Item 1A risk factor headed 'Matters concerning talc,' disclosing that personal injury claims alleging talc causes cancer 'may have a material adverse effect on the Company's results of operations and cash flows.'
Claim scope
That J&J disclosed talc litigation as a material financial risk factor in its own FY2023 SEC filing.
What this source does not establish
A securities-law risk disclosure is not an admission of liability or causation; do not present it as one. The filing simultaneously states the Company's confidence in the safety of its talc products.
Limitations
Pair with the litigation-docket records; the risk-factor framing ('alleging') must be preserved when quoting.
Source
Sec Filing — Johnson & Johnson Form 10-K FY2023, SEC accession 0000200406-24-000013 (filed 2024-02-16), Item 1A 'Matters concerning talc'